Document Detail


Ethical and Policy Issues in the Clinical Translation of Stem Cells: Report of a Focus Session at the ISSCR Tenth Annual Meeting.
MedLine Citation:
PMID:  23217422     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Alongside the scientific barriers to the clinical translation of stem cell research are ethical and regulatory hurdles. Some of these challenges described by the Ethics and Public Policy Committee at the ISSCR Tenth Annual Meeting are presented here.
Authors:
Kazuto Kato; Jonathan Kimmelman; Jason Robert; Douglas Sipp; Jeremy Sugarman
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cell stem cell     Volume:  11     ISSN:  1875-9777     ISO Abbreviation:  Cell Stem Cell     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101311472     Medline TA:  Cell Stem Cell     Country:  United States    
Other Details:
Languages:  eng     Pagination:  765-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Department of Biomedical Ethics and Public Policy, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita 565-0871, Japan; Institute for Integrated Cell-Material Sciences, Kyoto University, Ushinomiya-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. Electronic address: katok@eth.med.osaka-u.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The harmonies played by TGF-? in stem cell biology.
Next Document:  A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency n...